Tredje AP-fonden’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$13.1M Sell
24,901
-1,686
-6% -$946K 0.06% 296
2026
Q1
$14.9M Buy
+26,587
New +$17M 0.08% 233
2022
Q4
– Sell
-8,200
Closed -$2.67M – 544
2022
Q3
$2.67M Hold
8,200
– – 0.06% 266
2022
Q2
$2.88M Hold
8,200
– – 0.07% 193
2022
Q1
$4.49M Hold
8,200
– – 0.09% 182
2021
Q4
$5.4M Buy
8,200
+2,400
+41% +$1.51M 0.1% 167
2021
Q3
$3.61M Buy
5,800
+1,000
+21% +$672K 0.08% 183
2021
Q2
$3.03M Hold
4,800
– – 0.06% 156
2021
Q1
$2.35M Hold
4,800
– – 0.06% 174
2020
Q4
$2.4M Buy
+4,800
New +$2.15M 0.06% 168
2020
Q1
– Sell
-2,583
Closed -$674K – 321
2019
Q4
$674K Buy
2,583
+1,093
+73% +$288K 0.03% 337
2019
Q3
$405K Buy
1,490
+321
+27% +$89.3K 0.02% 375
2019
Q2
$322K Sell
1,169
-702
-38% -$173K 0.02% 388
2019
Q1
$418K Buy
+1,871
New +$386K 0.02% 377
2018
Q2
– Sell
-6,310
Closed -$1.21M – 467
2018
Q1
$1.21M Buy
6,310
+720
+13% +$133K 0.04% 397
2017
Q4
$874K Sell
5,590
-2,550
-31% -$401K 0.03% 445
2017
Q3
$1.27M Sell
8,140
-3,700
-31% -$585K 0.04% 405
2017
Q2
$1.91M Sell
11,840
-1,030
-8% -$167K 0.07% 322
2017
Q1
$1.99M Sell
12,870
-1,272
-9% -$175K 0.08% 296
2016
Q4
$1.66M Buy
14,142
+4,782
+51% +$546K 0.07% 318
2016
Q3
$1.05M Buy
9,360
+7,480
+398% +$788K 0.05% 376
2016
Q2
$175K Buy
+1,880
New +$161K 0.01% 516

Other funds holding IDXX

Tredje AP-fonden's IDXX Position: Q2 2026 in Review

Tredje AP-fonden reduced its Idexx Laboratories (IDXX) stake by 6.3% in Q2 2026, selling an estimated $946K and leaving 24,901 shares worth $13.1M. The position accounts for 0.06% of the portfolio, ranked #296.

Tredje AP-fonden first reported a position in IDXX in Q2 2016 and has held it in 22 quarters since. The position peaked at $14.9M in Q1 2026. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Tredje AP-fonden held 24,901 shares of Idexx Laboratories worth $13.1M as of Q2 2026.
  • Tredje AP-fonden sold 1,686 Idexx Laboratories shares in Q2 2026, an estimated $946K.
  • Idexx Laboratories made up 0.06% of Tredje AP-fonden's portfolio in Q2 2026, its #296 holding.
  • Tredje AP-fonden first reported a position in Idexx Laboratories in Q2 2016 and has held it in 22 quarters since.
  • Tredje AP-fonden's Idexx Laboratories position peaked at $14.9M in Q1 2026.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Tredje AP-fonden's 13F filing for Q2 2026, filed 10 Aug 2026.